Literature DB >> 6887943

Sulindac for polyposis of the colon.

W R Waddell, R W Loughry.   

Abstract

Four members of a Gardner's syndrome family had rectal and colon polyposis treated with nonsteroid anti-inflammatory drugs. Three of these patients had had subtotal colectomy and ileoproctostomy and the residual polyps arose in the rectal mucosa. The polyps almost completely disappeared when sulindac was administered. Indomethacin therapy over the course of a preceding year was ineffective in one of these patients. One patient (case 4) had diffuse polyposis in an intact colon. After sulindac therapy for a year, only three small mucosal polyps could be identified by air contrast barium enema and colonoscopic examination. These observations confirm those of Pollard and Luckert [1,2] on rats with chemically induced polyposis of the intestinal tract.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6887943     DOI: 10.1002/jso.2930240119

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  90 in total

1.  [Clinical research in Germany].

Authors:  H D Söling
Journal:  Med Klin (Munich)       Date:  1999-05-15

2.  COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.

Authors:  B J Whittle
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

3.  Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.

Authors:  C S Williams; A P Goldman; H Sheng; J D Morrow; R N DuBois
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

4.  Effects of sulindac on sporadic colorectal adenomatous polyps.

Authors:  N Matsuhashi; A Nakajima; Y Fukushima; Y Yazaki; T Oka
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 5.  Chemoprevention in familial adenomatous polyposis.

Authors:  Brian Kim; Francis M Giardiello
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

6.  Occult progression by Apc-deficient intestinal crypts as a target for chemoprevention.

Authors:  Jared M Fischer; Arnout G Schepers; Hans Clevers; Darryl Shibata; R Michael Liskay
Journal:  Carcinogenesis       Date:  2013-08-29       Impact factor: 4.944

7.  Resection of over 290 polyps during emergency surgery for four intussusceptions with Peutz-Jeghers syndrome: Report of a case.

Authors:  Koho Akimaru; Shuji Katoh; Shingo Ishiguro; Kenji Miyake; Kimiyoshi Shimanuki; Takashi Tajiri
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

8.  Chemoprevention of colorectal cancer in Japan: a brief introduction to current clinical trials.

Authors:  Hideki Ishikawa; Tomiyo Nakamura; Atsuko Kawano; Nobuhisa Gondo; Toshiyuki Sakai
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis.

Authors:  Wei-Hao Sun; Qian Yu; Hong Shen; Xi-Long Ou; Da-Zhong Cao; Ting Yu; Cheng Qian; Feng Zhu; Yun-Liang Sun; Xi-Ling Fu; Han Su
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

10.  Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.

Authors:  S J Shiff; L Qiao; L L Tsai; B Rigas
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.